LSBCF (LakeShore Biopharma Co) Payments of Debt: $-36.16 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Payments of Debt?

LakeShore Biopharma Co LSBCF Payments of Debt is $-36.16 Mil as of Mar. 2025.

LakeShore Biopharma Co's Payments of Debt for the six months ended in Mar. 2025 was $0.00 Mil.

LakeShore Biopharma Co's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2025 was $-36.16 Mil.

LakeShore Biopharma Co Payments of Debt Related Terms

LakeShore Biopharma Co Payments of Debt Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Payments of Debt Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Payments of Debt
-49.73 -7.81 -21.26 -57.88 -46.68

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Payments of Debt Get a 7-Day Free Trial Premium Member Only -13.92 -21.43 -36.16 0.00 0.00

LakeShore Biopharma Co Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-36.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-36.16 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Payments of Debt of $-36.16 Mil as of Mar. 2025. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Payments of Debt too high?
LakeShore Biopharma Co's current Payments of Debt is $-36.16 Mil.
How does LakeShore Biopharma Co's Payments of Debt compare to ACUT and PPCB?
LakeShore Biopharma Co's Payments of Debt of $-36.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Payments of Debt is $-36.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Payments of Debt of $-36.16 Mil. The current Payments of Debt is $-36.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Payments of Debt is $-36.16 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.